Mucocutaneous manifestations several cutaneous syndromes

Mucocutaneous manifestations several cutaneous
syndromes are related to cancer. several of those skin
l esions are uncommon, and therefore the association with malignancy
is stronger. a number of the cutaneous findings are common and
might be related to benign conditions. it's beyond the
scope of this review to explain all of those mucocutaneous
manifestations. table 23. four shows a compilation of the syndromes
related to lung cancer. 122, 139, 140
hematologic syndromes and vascular manifestations
anemia may be a common problem in cancer patients,
with several attainable causes like bleeding, nutritional deficiencies,
and bone marrow involvement by the malignancy.
anemias with no apparent cause is termed paraneoplastic.
red blood cells are typically normochromic or slightly hypochromic,
ferritin levels and that iron stores are normal or increased,
and erythropoietin levels and reticulocyte counts are inappropriately
low. the anemia might be connected to many cytokines
that blunt erythropoietin response. 141 rarely autoimmune hemolytic
anemia, red cell aplasia, and microangiopathic hemolytic
anemia are related to lung cancers. 142, 143
leukocytosis is observed in a few patients and might be related
to the effects of il-1 or granulocyte-stimulating issue. 144
leukopenia is rare. each eosinophilia and monocytosis can
occur infrequently. thrombocytosis may be a fairly common occurrence
and might be connected to cytokine release of il-6 or thrombopoetin.
145, 146 an idiopathic thrombocytopenia purpura-like
syndrome will rarely be seen in lung cancer. 147
trousseau syndrome is one among the earliest paraneoplastic
syndromes described. it represents an association between
thrombosis and malignancy. it's seen in many malignancies,
as well as gastrointestinal, lung, breast, ovarian, and prostate
cancers. 148 deep vein thrombosis of the lower extremities and
pulmonary embolism are the foremost common presentations, although
unusual location of thromboses will occur. the origin
is in all probability multifactorial and might embrace release of procoagulant
materials (particularly from mucin), release of cytokines
that have procoagulant activity, platelet hyperactivity, and therefore the
release of tissue factors via abnormal tumor vasculature. 149
therapy with heparin or warfarin might not give satisfactory
treatment.
nonbacterial thrombotic endocarditis is related to
sterile verrucous fibrin platelet lesions within the left-sided heart
valves. it's most commonly related to adenocarcinoma of
the lung. 150 this syndrome will cause tumor embolisms to the
brain and different organs. anticoagulants are typically not useful.